HomeAI · summaries
Storia in 2 fonti
United Therapeutics Expands Immune Therapy Pipeline With Thymmune - United Therapeutics (NASDAQ:UTHR)
United Therapeutics (UTHR) acquires Thymmune Therapeutics for $140M upfront, with up to $160M in milestone-based payments.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
FDA Approval Positions United Therapeutics To Broaden Access To Donor Lungs - United Therapeutics (NASDAQ
United Therapeutics received FDA approval for LungFX, a device designed to expand donor lung use in transplantation.
- ·
morningstar.com
United Therapeutics Corporation Acquires Thymmune Therapeutics
United Therapeutics Corporation Acquires Thymmune Therapeutics
- ·
United Therapeutics Expands Immune Therapy Pipeline With Thymmune - United Therapeutics (NASDAQ:UTHR)
United Therapeutics (UTHR) acquires Thymmune Therapeutics for $140M upfront, with up to $160M in milestone-based payments.